Bio SB, a molecular pathology company based in Santa Barbara, CA, has announced the launch of two new micro-polymer based detection systems for in-vitro diagnostic use; PolyDetector and PolyDetector Plus. These new products complement the Bio SB Biotin/Streptavidin based ImmunoDetector as part of the company’s portfolio of highly sensitive and cost-effective IVD Immunohistochemistry detection systems for research and clinical use.
The Bio SB PolyDetector and PolyDetector Plus systems are nonbiotin, micro-polymeric detection system that allows for the demonstration of antigens in formalin-fixed paraffin-embedded tissue, cryostat sections, blood smears, cytosmears, and cell preparations. The Bio SB PolyDetector and PolyDetector Plus detection systems were developed using proprietary tandem hyperlabelling micro-polymer technology to directly label immunoglobulin fractions with enzymes. According to company spokespersons, this technology ensures consistent and reproducible immunostaining for nuclear, cytoplasmic, and membranous antigens across different tissue types.
Bio SB performs R&D, production, distribution, and marketing of products for immunohistochemistry (IHC), immunocytochemistry (ICC), fluorescent in situ hybridization (FISH), chromogenic in situ hybridization (CISH), liquid-based cytology (LBC), and polymerase chain reaction (PCR) technologies that meet international standards for applications in molecular pathology, cancer research, microbiology, immunology, and genetics. BIO SB manufactures and develops products in accordance with FDA QSR 21 CFR Part 820 cGMP and ISO 13485:2003 certifications. Learn more about products offered by Bio SB.
Read more
